Bhandi neMugwagwa: Kushandira Pamwe, Kuwirirana uye Kukunda-Kukunda
zvigadzirwa

Zvigadzirwa

DL-Phenylalanine CAS:150-30-1 Mutengo wemugadziri

DL-phenylalanine, inozivikanwawo seDLPA, ine mhando dzakasiyana dzeamino acid inokosha phenylalanine.

L-form chinhu chechisikigo, chinowanzo kuwanikwa muzvikafu zvine mapuroteni akawanda. L-phenylalanine inofungidzirwawo kuti inobatsira kukurudzira makemikari ekusimudzira manzwiro muuropi, akadai sedopamine nenorepinephrine.

Rudzi rwe "D" rweamino acid iyi rwakagadzirwa nemakemikari. D-phenylalanine inofungidzirwa kuti inokanganisa kududzirwa uye kupindura kweuropi nehurongwa hwetsinga kumarwadzo emuviri.

DL-phenylalanine inoshandiswa kuderedza kushushikana kudiki uye mamwe matambudziko emanzwiro, pamwe nekusagadzikana kwemuviri nekurwadziwa. Ichi chinwiwa chinoshandiswawo pakuratidza zviratidzo zvekurega opium m. DLPA inowanzoshandiswawo pamwe chete nezvimwe zvinovaka muviri zvinokurudzira manzwiro, uye inotorwa senzira yekusimudzira mashandiro etsinga.

.


Ruzivo rweChigadzirwa

Matagi eChigadzirwa

Kushandiswa uye Mhedzisiro

DL-Phenylalanine musanganiswa we phenylalanine, amino acid inonhuhwirira ine antidepressant, analgesic uye appetite depressant. DL-phenylalanine inogona kuverengerwa nebasa rayo rekutanga mukugadzirwa kwe neurotransmitters norepinephrine ne dopamine. Kuwanda kwe norepinephrine muuropi uye dopamine kunofungidzirwa kuti kwakabatana nemigumisiro ye antidepressant. Mushonga uyu une basawo mukuderedza kushanduka kwemafungiro e premenstrual syndrome (PMS), kuwedzera simba uye kungwarira kwepfungwa uye kuwedzera kugona kwekutarisa kune vanhu vane attention deficit hyperactivity disorder (ADHD).

Kurongedza Chigadzirwa:

试剂包装2

Mamwe Mashoko:

Kuumbwa C9H11NO2
Kuyedza 99%
Chitarisiko Upfu chena
Nhamba yeCAS 150-30-1
Kurongedza Diki uye rakakura
Hupenyu hweSherufu makore maviri
Kuchengetera Chengeta munzvimbo inotonhorera uye yakaoma
Chitupa ISO.

 


  • Yakapfuura:
  • Zvinotevera:

  • Nyora meseji yako pano woitumira kwatiri